- (1:50) - What Sectors Of The Market Should Investor Be Keeping An Eye On?
- (5:30) - The Recent Positive Run For The Cannabis Industry
- (11:20) - What Is The Impact To The Industry With Changing State Laws
- (17:35) - When Could Investors Expect A Federal Legalization?
- (25:00) - What Sectors Of The Industry Are Showing The Most Growth?
- (33:50) - Amplify Seymour Cannabis ETF: CNBS
- (46:45) - Episode Roundup: Podcast@Zacks.com
In this episode of ETF Spotlight, I speak with Tim Seymour, CIO of Seymour Asset Management and co-host of CNBC's Fast Money, and Christian Magoon, CEO of Amplify ETFs. We discuss cannabis investing and the Amplify Seymour Cannabis ETF CNBS, which is actively managed by Tim.
Cannabis stocks & ETFs have done quite well over the past few weeks as a Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
New Jersey, Arizona, Montana and South Dakota have voted to make recreational marijuana legal and Mississippi approved its medical use, starting next year. Medical use of marijuana is already legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies. Further, the industry is evolving rapidly and therefore these stocks are very volatile. What lies ahead?
GW Pharmaceuticals (OTC:GWPRF) GWPH, Canopy Growth (NYSE:CGC) Corporation CGC, Cronos Group (NASDAQ:CRON) CRON, Innovative Industrial Properties (NYSE:IIPR) IIPR, GrowGeneration (NASDAQ:GRWG) GRWG and Aphria (NASDAQ:APHA) APHA are CNBS’s top holdings. What do investors need to know about these companies? We also discuss recent quarterly earnings of major cannabis companies.
Make sure to be on the lookout for the next edition of ETF Spotlight! If you have any comments or questions, please email podcast@zacks.com.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report
Innovative Industrial Properties, Inc. (IIPR): Free Stock Analysis Report
Canopy Growth Corporation (CGC): Free Stock Analysis Report
Cronos Group Inc. (CRON): Free Stock Analysis Report
Aphria Inc. (APHA): Free Stock Analysis Report
GrowGeneration Corp. (GRWG): Free Stock Analysis Report
Amplify Seymour Cannabis ETF (CNBS): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research